Colorectal Cancer and Peritoneal Metastatic Disease
Colorectal cancer research is a major focus, with attention to peritoneal metastases arising from colorectal origin, including both resectable and unresectable disease. The clinical work also includes treatment strategies for locally recurrent rectal cancer and advanced intra-abdominal spread.
- Peritoneal metastases of colorectal origin
- Resectable and unresectable metastatic disease
- Locally recurrent rectal cancer
Interest extends to perioperative and regional treatment approaches in advanced bowel cancer, with emphasis on disease control and surgical eligibility.
Locally Advanced Rectal Cancer
The sponsor is actively involved in locally advanced rectal cancer, including high-risk rectal cancer and treatment-resistant presentations. Research activity centers on improving tumour response before surgery and on strategies relevant to organ preservation.
- High-risk locally advanced rectal cancer
- Neoadjuvant treatment strategies
- Clinical and pathological response assessment
Work in this area also covers comparisons of treatment pathways in patients considered for surgery or a watch-and-wait approach.
Pancreatic Cancer
Pancreatic cancer is another important area of interest, with research directed toward systemic treatment optimisation and individualized exposure to 5-fluorouracil within combination therapy. The clinical focus includes treatment tolerance and safety in this aggressive malignancy.
- Pancreatic cancer systemic therapy
- 5-fluorouracil exposure and treatment optimisation
- Safety and feasibility in combination chemotherapy
This reflects an interest in refining chemotherapy delivery for patients with advanced pancreatic disease.
Perioperative and Surgical Recovery Care
Clinical research also addresses perioperative care after minimally invasive colorectal surgery, with attention to post-operative recovery, wound management, and pain control. These studies examine supportive approaches that may influence recovery after colorectal procedures.
- Minimally invasive colorectal surgery
- Post-operative recovery
- Local analgesic wound infusion
The sponsor’s surgical research spans both cancer-related operations and recovery-focused interventions.
Combined Modality and Regional Treatment Approaches
Research activity includes chemotherapy, chemoradiotherapy, bevacizumab-based regimens, and intraperitoneal therapy for advanced gastrointestinal malignancies. These interests reflect work in multimodal treatment for difficult-to-treat colorectal and peritoneal disease.
- Induction chemotherapy
- Chemoradiotherapy combinations
- Intraperitoneal treatment strategies
The therapeutic scope connects systemic and regional approaches across advanced rectal, colorectal, and peritoneal cancer settings.
